Towards Healthcare
Middle East and Africa Pharmaceutical Market to Promote USD 141.3 Bn by 2034

Middle East and Africa Pharmaceutical Market Future Prospects

Market insights predict, the Middle East and Africa pharmaceutical industry is expected to grow from USD 75.15 billion in 2024 to USD 141.3 billion by 2034, driven by a CAGR of 6.52%. This market is rising due to increasing chronic disease prevalence, growing healthcare investments, expanding local manufacturing, and improved access through digital and donor-driven initiatives.

  • Insight Code: 6277
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: October 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Shivani Zoting is a dedicated research analyst specializing in the healthcare industry. With a strong academic foundation, a B.Sc. in Biotechnology and an MBA in Pharmabiotechnology, she brings a unique blend of scientific understanding and market strategy to her research.

Shivani contributes to Towards Healthcare and plays an active role at Precedence Research, where she focuses on delivering in-depth market intelligence, competitive analysis, and trend forecasting across pharmaceuticals, medical devices, digital health, and healthcare services. Her insights support healthcare companies, investors, and policymakers in making data-backed decisions in a highly regulated and rapidly evolving sector.

Additionally, Shivani collaborates with Statifacts, further expanding her healthcare domain reach by engaging in diverse projects across global markets. Her strength lies in transforming complex clinical and commercial data into strategic narratives that help stakeholders navigate the future of healthcare.

FAQ's

The Middle East and Africa pharmaceutical market currently in 2025 records USD 80.05 billion and is anticipated to grow to USD 141.3 billion by 2034, advancing at a CAGR of 6.52% from 2024 to 2034.

GCC is currently Middle East and Africa pharmaceutical market due to rising chronic conditions and government initiatives to tackle them.

Rising cancer diagnoses, increased need for treatment, and increased radiation use in research labs are some of the major developments.

FDA, WHO, National Institutes of Health, International Trade Administration, UNCTAD, etc.